MK
Meenu Khaneja
About Meenu Khaneja
Data last updated:
Meenu Khaneja is a Director at Radicon Laboratories Limited (since 2007), Director at Ambitree India Private Limited (since 2019) and Director at Shree Radhey Gobind Pharmaceuticals Private Limited (since 2012), and holds 2 more current directorships. The companies operate in Pharma and Wood. The 4 current companies with reported revenue have a combined latest revenue of ₹38.14 Cr; the largest is Radicon Laboratories Limited at ₹22.99 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Feb 2007 | 2007 | ₹22.99 Cr (FY 2025) | Active | |
| Director | 26 Apr 2019 | 2019 | ₹6.75 Cr (FY 2024) | Active | |
| Director | 19 Dec 2012 | 2012 | ₹6.63 Cr (FY 2025) | Active | |
| Director | 14 Feb 2006 | 2006 | ₹1.77 Cr (FY 2022) | Active | |
| Director | 30 Nov 2023 | 2023 | Active |
Board colleagues of Meenu Khaneja
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahima Khaneja | 08941196 | Radicon Laboratories Limited , Kritajna Beauty World Private Limited | Director |
| Sagar Khaneja | 08018371 | Radicon Laboratories Limited , Shree Radhey Gobind Pharmaceuticals Private Limited and 1 more | Director |
| Lakshay Khanna | 08435344 | Ambitree India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Meenu Khaneja
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meenu Khaneja
Meenu Khaneja currently holds 5 directorships: Radicon Laboratories Limited (Director, since 01 Feb 2007, revenue ₹22.99 Cr (FY 2025)); Ambitree India Private Limited (Director, since 26 Apr 2019, revenue ₹6.75 Cr (FY 2024)); Shree Radhey Gobind Pharmaceuticals Private Limited (Director, since 19 Dec 2012, revenue ₹6.63 Cr (FY 2025)); Shree Gobind Pharmaceuticals Private Limited (Director, since 14 Feb 2006, revenue ₹1.77 Cr (FY 2022)); Kritajna Beauty World Private Limited (Director, since 30 Nov 2023).
Meenu Khaneja was first appointed on 14 Feb 2006 as Director at Shree Gobind Pharmaceuticals Private Limited. The most recent appointment on record is 30 Nov 2023 at Kritajna Beauty World Private Limited.
The 4 current companies of Meenu Khaneja that report revenue have a combined latest revenue of ₹38.14 Cr: Radicon Laboratories Limited ₹22.99 Cr (FY 2025); Ambitree India Private Limited ₹6.75 Cr (FY 2024); Shree Radhey Gobind Pharmaceuticals Private Limited ₹6.63 Cr (FY 2025); Shree Gobind Pharmaceuticals Private Limited ₹1.77 Cr (FY 2022).
The current boards of Meenu Khaneja's companies include Mahima Khaneja (Radicon Laboratories Limited), Sagar Khaneja (Radicon Laboratories Limited), Lakshay Khanna (Ambitree India Private Limited).